Desvenlafaxine 50 and 100 mg/d in the Treatment of Major Depressive Disorder: An 8-Week, Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial and a Post Hoc Pooled Analysis of Three Studies: Mental Health Disorders

Bibliographische Detailangaben

Veröffentlicht in:	Clinical therapeutics 2009, Vol.31 (THEM), p.1405-1423
Hauptverfasser:	TOURIAN, Karen A, PADMANABHAN, S. Krishna, GROARK, James, BRISARD, Claudine, FARRINGTON, Deborah
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult and adolescent clinical studies Biological and medical sciences Depression Medical sciences Mood disorders Pharmacology. Drug treatments Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!